These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1677044

  • 1. Effects of subcutaneous and intracerebroventricular administration of the sigma receptor ligand 1,3-Di-o-tolylguanidine on body temperature in the rat: interactions with BMY 14802 and rimcazole.
    Bejanian M, Pechnick RN, Bova MP, George R.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):88-93. PubMed ID: 1677044
    [Abstract] [Full Text] [Related]

  • 2. Two subtypes of enteric non-opioid sigma receptors in guinea-pig cholinergic motor neurons.
    Coccini T, Costa LG, Manzo L, Candura SM, Iapadre N, Balestra B, Tonini M.
    Eur J Pharmacol; 1991 May 30; 198(1):105-8. PubMed ID: 1680712
    [Abstract] [Full Text] [Related]

  • 3. Up-regulation of rat cortical sigma receptors after subchronic administration of rimcazole and 1,3-di(2-tolyl)guanidine.
    Manallack DT, Beart PM.
    Neuropharmacology; 1988 Nov 30; 27(11):1201-3. PubMed ID: 2849732
    [Abstract] [Full Text] [Related]

  • 4. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
    Maj J, Rogóz Z, Skuza G.
    Pol J Pharmacol; 1996 Nov 30; 48(4):379-95. PubMed ID: 9112678
    [Abstract] [Full Text] [Related]

  • 5. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
    Terleckyj I, Sonsalla PK.
    J Pharmacol Exp Ther; 1994 Apr 30; 269(1):44-50. PubMed ID: 7513362
    [Abstract] [Full Text] [Related]

  • 6. Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons.
    Steinfels GF, Tam SW, Cook L.
    Neuropsychopharmacology; 1989 Sep 30; 2(3):201-8. PubMed ID: 2571340
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological evidence for the involvement of sigma sites in DTG-induced contralateral circling in rats.
    Bastianetto S, Perrault G, Sanger DJ.
    Neuropharmacology; 1995 Jan 30; 34(1):107-14. PubMed ID: 7623959
    [Abstract] [Full Text] [Related]

  • 8. Effect of 1,3-di-o-tolylguanidine (DTG), rimcazole and EMD 57445, the sigma receptor ligands, in the forced swimming test.
    Skuza G, Rogóz Z.
    Pol J Pharmacol; 1997 Jan 30; 49(5):329-35. PubMed ID: 9566032
    [Abstract] [Full Text] [Related]

  • 9. 1,3-Di-o-tolylguanidine (DTG) differentially affects acute and tonic formalin pain: antagonism by rimcazole.
    Kest B, Mogil JS, Sternberg WF, Pechnick RN, Liebeskind JC.
    Pharmacol Biochem Behav; 1995 Sep 30; 52(1):175-8. PubMed ID: 7501662
    [Abstract] [Full Text] [Related]

  • 10. Discriminative stimulus characteristics of BMY 14802 in the pigeon.
    Vanecek SA, Essman WD, Taylor DP, Woods JH.
    J Pharmacol Exp Ther; 1998 Jan 30; 284(1):1-9. PubMed ID: 9435153
    [Abstract] [Full Text] [Related]

  • 11. Influence of 1,3-di-o-tolylguanidine and rimcazole, selective sigma ligands, on apomorphine and neuroleptic effects.
    Maj J, Rogóz Z, Skuza G.
    Pol J Pharmacol; 1993 Jan 30; 45(3):327-30. PubMed ID: 8106091
    [Abstract] [Full Text] [Related]

  • 12. Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine.
    Beart PM, O'Shea RD, Manallack DT.
    J Neurochem; 1989 Sep 30; 53(3):779-88. PubMed ID: 2569504
    [Abstract] [Full Text] [Related]

  • 13. Sigma sites mediate DTG-evoked hypothermia in rats.
    Rawls SM, Baron DA, Geller EB, Adler MW.
    Pharmacol Biochem Behav; 2002 Nov 30; 73(4):779-86. PubMed ID: 12213522
    [Abstract] [Full Text] [Related]

  • 14. Antinociception following 1,3,-di-o-tolylguanidine, a selective sigma receptor ligand.
    Kest B, Mogil JS, Sternberg WF, Pechnick RN, Liebeskind JC.
    Pharmacol Biochem Behav; 1995 Apr 30; 50(4):587-92. PubMed ID: 7617705
    [Abstract] [Full Text] [Related]

  • 15. Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic.
    Ceci A, Smith M, French ED.
    Eur J Pharmacol; 1988 Sep 01; 154(1):53-7. PubMed ID: 2903063
    [Abstract] [Full Text] [Related]

  • 16. Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate.
    Levant B, Nemeroff CB.
    J Pharmacol Exp Ther; 1990 Jul 01; 254(1):330-5. PubMed ID: 1973198
    [Abstract] [Full Text] [Related]

  • 17. Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor.
    Earley B, Burke M, Leonard BE, Gouret CJ, Junien JL.
    Brain Res; 1991 Apr 19; 546(2):282-6. PubMed ID: 1676927
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sigma receptor-mediated effects of a new antiulcer agent, KB-5492, on experimental gastric mucosal lesions and gastric alkaline secretion in rats.
    Hara H, Tanaka K, Harada Y, Sukamoto T.
    J Pharmacol Exp Ther; 1994 May 19; 269(2):799-805. PubMed ID: 8182548
    [Abstract] [Full Text] [Related]

  • 20. Sigma receptor-mediated emetic response in pigeons: agonists, antagonists and modifiers.
    Hudzik TJ, De Costa BR, McMillan DE.
    Eur J Pharmacol; 1993 May 19; 236(2):279-87. PubMed ID: 8100532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.